Search Results 101-110 of 16777 for alt

  1. A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients - Mayo Clinic

    the presence of elevated serum CK levels, ALT, or AST, up to 5 times the ULN are acceptable if other liver tests are normal. b. If the total bilirubin ...

  2. Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study - Mayo Clinic

    Note: Subjects with ALT/AST/ALP ≥ 3x ULN AND TB ≥2x ULN that have been chronically stable (for >1 year on more than one assessments) due to known liver ...

  3. A Study to Evaluate Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients with Chronic Myeloid Leukemia and Persistently- Detectable Minimal Residual Disease - Mayo Clinic

    AST (SGOT) and ALT (SGPT) ≤ 2.5 X ULN OR ≤ 5 X ULN for subjects with liver metastases. ALT: ______ Institutional ULN: ______ Date of Test: ______; AST ...

  4. A Study Comparing a Vaccine with or without an Autologous Tumor Lysate to Treat Stage III or IV Melanoma to Prevent Recurrence - Mayo Clinic

    ALT and AST ≤ 1.5 ULN. For women of child-bearing potential, agreement to use adequate birth control (abstinence, hysterectomy, bilateral oophorectomy ...

  5. A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of Chronic Spontaneous Urticaria in Adults Inadequately Controlled by H1-antihistamines - Mayo Clinic

    Aminotransferase (ALT) levels of more than 1.5 x upper limit of normal (ULN) or. International Normalized Ratio (INR) of more than 1.5 at screening. Note ...

  6. An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies - Mayo Clinic

    AST or ALT > 1.5 × ULN; ALP > 1.5 × ULN (> 3 × ULN if related to underlying disease); Creatinine clearance ≤60 mL/min based on the site's standard formula ...

  7. MicroOrganoSphere Drug Screen Pilot Trial in Colorectal Cancer (CRC) - Mayo Clinic

    Hemoglobin ≥ 8 g/dL (transfusions are permitted to achieve baseline hemoglobin level);. ALT/AST (alanine aminotransferase (ALT) / aspartate aminotransferase ...

  8. Analyses Of Metabolic Agents Following Brain Radiation - Mayo Clinic

    Alanine aminotransferase (ALT) and aspartate transaminase (AST) < 3 x ULN (≤ 5 x ULN for patients with baseline liver disease);; Serum creatinine ≤ 1.5 mg ...

  9. Hepatic encephalopathy - Symptoms and causes - Mayo Clinic

    This serious liver condition can harm your brain and lead to coma or death. Find out how to treat this liver condition, including with a liver transplant.

  10. Omega-3 Fatty Acids To Combat Sarcopenia - Mayo Clinic

    Chronic active liver disease (Bilirubin > 17mmol/L, AST>144IU/L, or ALT>165IU/L); Anti-coagulant therapy (warfarin/heparin); INR >3; Use of systemic ...